For the last five quarters, Watson Pharmaceuticals (NYSE:WPI) has exceeded analyst expectations. The company will try to continue the streak when it reports its latest earnings on Thursday, July 26, 2012.
Analysts currently expect Watson Pharmaceuticals to come in with earnings of $1.38 per share on revenues of $1.35 billion. Estimates from analysts range from earnings per share to earnings per share. Over the past two months, the average estimate has moved down from $1.40.
The stock fell $4.67 per share between May 29, 2012 and June 4, 2012.
Company Fundamental Trends
Analysts are bullish on the stock as 16 analysts rate it as a buy and there are no sell ratings. That rating hasn't budged in three months as the average analyst rating of the stock has remained steadfast.
Last Quarter's Results
In the first quarter, profit rose 21% to $54.8 million (43 cents a share) from $45.3 million (36 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 73.9% to $1.52 billion from $876.5 million.
Reporting Period: 2Q
Date of Release: Thursday, July 26, 2012 before market open
Revenue Estimate: $1.35 billion
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)